Rain Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Rain Therapeutics's estimated annual revenue is currently $5.3M per year.(i)
  • Rain Therapeutics's estimated revenue per employee is $87,833
  • Rain Therapeutics's current valuation is $315.7M. (January 2022)

Employee Data

  • Rain Therapeutics has 60 Employees.(i)
  • Rain Therapeutics grew their employee count by 33% last year.

Rain Therapeutics's People

NameTitleEmail/Phone
1
Executive Assistant To CEO and Chief Scientific OfficerReveal Email/Phone
2
EVP and CMOReveal Email/Phone
3
Sr. Director, Analytical ChemistryReveal Email/Phone
4
Chief Science OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Rain Therapeutics?

Rain Therapeutics is a San Francisco Bay Area-based biotechnology company, focused on developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver.

keywords:N/A

N/A

Total Funding

60

Number of Employees

$5.3M

Revenue (est)

33%

Employee Growth %

$315.7M

Valuation

N/A

Accelerator

Rain Therapeutics News

2022-04-17 - We're Not Very Worried About Rain Therapeutics' (NASDAQ:RAIN) Cash Burn Rate

How Is Rain Therapeutics' Cash Burn Changing Over Time? Because Rain Therapeutics isn't currently generating revenue, we consider it an early-...

2022-04-13 - Rain Therapeutics : Statement of Changes in Beneficial Ownership (Form 4)

Rain Therapeutics : Statement of Changes in Beneficial Ownership (Form 4) ; 1.Title of Security, 2. Transaction Date (Month/Day/Year), 2A. Deemed...

2022-03-30 - Rain Therapeutics Announces a Poster Presentation and ...

About Rain Therapeutics Inc. Rain Therapeutics Inc. is a late-stage precision oncology company developing therapies that target oncogenic...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.9M600%N/A
#2
$7.8M607%N/A
#3
$13.2M605%N/A
#4
$14.8M615%N/A
#5
$7.5M610%N/A